Shibasaburō Kitasato

Kitasato was born in the village of Kitasato in Higo Province, in what is now Kumamoto Prefecture. He studied at the medical school and hospital in Kumamoto, where the Dutch military physician Constant George van Mansveldt taught, and then entered Tokyo Medical School in 1874. After graduating in 1883 he joined the Home Ministry’s Sanitary Affairs Bureau. These were years when the Meiji state was building new systems for medical licensing, sanitation, epidemic control, and laboratory science; “Western medicine” was not one fixed package but a field of competing institutional models. ^{1 10 16}

The ministry sent him to Germany in late 1885, and in 1886 he began work with Robert Koch at Berlin’s Hygiene Institute. Koch’s group treated disease-specific microorganisms as objects that could be stained, separated in culture, compared, and tested in animals. Kitasato was not merely a recipient of this method: his work on anaerobic culture enlarged what the Berlin programme could investigate. ¹⁶

This transnational path should not be reduced to Japan “catching up” with Europe. The Home Ministry paid for expertise it intended to use in Japanese sanitary administration; Kitasato published in German scientific journals; and, on returning, he selected and reorganised Berlin practices for Japanese laboratories, courses, journals, hospitals, and epidemic work. Knowledge travelled in both directions, although European institutions and languages retained disproportionate power over international reputation. ¹⁰

The organism then called the tetanus bacillus—and now classified as Clostridium tetani—is an obligate anaerobe: ordinary exposure to oxygen impedes its growth. Material from tetanus wounds also contained other microbes. That combination made it difficult to decide whether one organism, a microbial partnership, or a soluble poison caused the spasms. ²

Kitasato exploited two material properties. He grew wound material in a vessel from which oxygen was displaced by hydrogen, and he heated a mixed culture to about 80°C. The tetanus organism’s spores survived conditions that killed many accompanying bacteria; subsequent anaerobic growth yielded a culture he could examine and inoculate into mice, guinea pigs, rabbits, and other animals. The procedure joined an apparatus, a selective heat step, and animal passage rather than relying on visual resemblance alone. ²

The disease appeared after inoculation even though organisms were not found throughout the animal’s organs. Kitasato therefore suggested that a toxic product acting at a distance was responsible. Other groups soon isolated and investigated tetanus toxin. His paper is valuable as a contemporary record of the procedure and reasoning, but it was written to establish his experimental claim and cannot by itself settle the near-simultaneous work of Tizzoni and Cattani. ^{2 3}

Behring and Kitasato’s two-page paper, published on 4 December 1890, described blood from immunised rabbits neutralising tetanus toxin and transferring protection to mice. This was a decisive argument for a soluble, specific protective activity in blood. The later term antitoxin named such activity; serum therapy used the cell-free portion of blood from an immunised animal to supply another body with temporary passive protection. ⁴

The experiment was neither a modern vaccine nor immediate proof of safe treatment in people. It depended on deliberate infection and immunisation of animals, and practical therapy still required reliable immunisation of larger animals, production, potency measurement, dosing, and clinical use. Diphtheria serum’s path to patients involved further work by Behring and Erich Wernicke, practical production in large animals and industry, clinical use, and parallel investigation at the Pasteur Institute. A success narrative that jumps directly from the 1890 mice to a universal cure erases both this labour and the uncertainty present at the time. ⁵

The 1901 Nobel record is evidence of uneven recognition, but it should be stated precisely. One nominator jointly proposed Behring and Kitasato for tetanus antitoxin and also credited Kitasato with plague work. The prize was awarded to Behring alone for serum therapy, “especially” its use against diphtheria. A nomination does not show that the committee judged both men’s contributions equal, and the award does not make Kitasato a co-developer of every later diphtheria-serum procedure. ¹³

In June 1894 the Japanese government sent Kitasato and a team to investigate plague in Hong Kong, then a British colony. Alexandre Yersin arrived for the Pasteur Institute several days later. Colonial medical officer James Lowson gave Kitasato’s established team early access to patients, post-mortems, and hospital facilities, while Yersin initially worked with fewer resources and less official assistance. The conditions of observation were unequal before either result circulated. ⁸

Both men reported bacteria associated with plague. Yersin consistently described a short bacillus taken from buboes that did not retain the Gram stain, matching the organism now called Yersinia pestis. Reports from Kitasato’s group varied: some early descriptions resembled the plague bacillus, while others called the organism Gram-positive, spherical or diplococcal, and motile. Contamination by another organism, probably a pneumococcus, is a plausible explanation, but the original cultures no longer exist for decisive retesting. ^{6 7}

Historians consequently reach different verdicts. David Bibel and T. H. Chen concluded that Kitasato probably did examine the plague organism during the investigation, even though later descriptions were compromised; other reviews give Yersin sole credit because his cultures and published account were consistent. The narrowest defensible conclusion is that Kitasato rapidly found plague-associated bacilli but did not leave an unambiguous, stable characterisation equivalent to Yersin’s. Renaming the organism for Yersin decades later did not retrospectively settle what Kitasato saw in June 1894. ^{7 8}

Kitasato’s English-language preliminary report appeared in The Lancet on 25 August 1894 after Lowson forwarded material from Hong Kong. It was a rapid claim produced through translation and editorial mediation, not a laboratory notebook or an independently refereed reconstruction. Ka-wai Fan shows that The Lancet and the British Medical Journal, along with Lowson and James Cantlie, formed rival reporting networks around Kitasato and Yersin. Priority was made in print as well as at the microscope. ^{6 9}

The celebrated contest also sidelines the people most affected. Plague was concentrated in Taipingshan, a densely inhabited Chinese working-class district. Colonial officials joined bacteriological claims to older ideas about “filth” and infected soil, searched and emptied homes, and debated demolition. Asked for advice, Kitasato supported removing polluted soil and radically disinfecting or burning parts of affected dwellings. Those measures were proposed before the rat–flea route had been established and extended medical authority over residents’ property and neighbourhoods. ¹⁴

This does not make laboratory identification irrelevant. It shows why a bacterium’s identification did not instantly resolve transmission, ecology, or policy. Investigators still debated soil, rats, direct contact, atmosphere, and housing; later work on rat fleas changed the explanatory centre. The episode therefore belongs to the history of colonial urban government as well as to the history of microbiology. ¹⁴

With support from educator and publisher Fukuzawa Yukichi and other allies, Kitasato opened a small private Institute for Infectious Diseases in Tokyo in 1892. In 1893 he established Tsukushigaoka Yōjōen, which institutional histories describe as Japan’s first specialist tuberculosis hospital. The sanatorium linked laboratory research with sustained clinical observation at a time when identifying the tubercle bacillus had not produced an effective curative drug. ¹²

The institute trained bacteriologists and published a specialist journal, adapting practices Kitasato had learned in Germany. Its success was also political. Yōko Yokota’s study places it within rivalry between physicians attached to sanitary administration and those based in the imperial university system. An 1899 plague emergency helped the administrative group secure state funding and expand bacteriology training; that year the institute became a national body under the Home Ministry. ^{10 11}

In 1914 the government transferred the institute from the Home Ministry to the Ministry of Education, a step toward incorporation into Tokyo Imperial University. Kitasato and senior colleagues resigned. On 5 November he founded the private Kitasato Institute on the Tsukushigaoka site. Remembering the split only as personal defiance is too narrow: it exposed competing views about whether bacteriology should answer primarily to public-health administration, university authority, or an autonomous research organisation. ^{10 11}

Kitasato later helped establish Keio University’s medical school and became its first dean in 1917. He also served as the first president of the Japan Medical Association, founded in 1916. These roles extended his influence from laboratory methods to professional organisation and medical education. ^{12 15}

Kitasato is often called a founder of modern Japanese medicine. The label is useful only if “founder” does not erase the Home Ministry that sponsored him, Koch’s multinational laboratory, Behring and other collaborators, Fukuzawa and private patrons, competing researchers in Bologna and Paris, trained assistants, hospital workers, patients, and experimental animals. His career was powerful because all of these elements were organised into a continuing programme.

His strongest scientific legacy lies neither in claiming every first nor in treating serum therapy as a finished cure. It lies in making an anaerobic pathogen manipulable, connecting toxin to transferable protection, and helping build Japanese institutions that could investigate, teach, publish, manufacture, and apply bacteriological knowledge. The plague controversy and Hong Kong’s intrusive control measures remain part of that legacy, because they reveal what laboratory authority could not yet know and what it could nevertheless empower governments to do.